Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

NOVIDOL 50 MG/ML SOLUCION PARA PULVERIZACION CUTANEA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/NOVIDOL 50 MG/ML SOLUCION PARA PULVERIZACION CUTANEA

Approved

STANDARD

NOVIDOL 50 MG/ML SOLUCION PARA PULVERIZACION CUTANEA

Menarini Consumer Healthcare S.A.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jun 12, 2023
Approval ID: 0dfb3288796978f1
Company: Menarini Consumer Healthcare S.A.U.
Type: Standard

Approval Details

Approval Id: 0dfb3288796978f1
Drug Cima Aemps Name: NOVIDOL 50 MG/ML SOLUCION PARA PULVERIZACION CUTANEA
Register Number: 88897
Holder Company Name: Menarini Consumer Healthcare S.A.U.
Marketing Company Name: Menarini Consumer Healthcare S.A.U.
Authorization Date: 2023-06-12
Dosage Form: SOLUCIÓN PARA PULVERIZACIÓN CUTÁNEA
Dose: 50 mg/ml
Route Of Administration: USO CUTÁNEO
Prescription Type: Sin Receta
Commercialized: Yes
Company Name: Menarini Consumer Healthcare S.A.U.

Active Ingredients

IBUPROFENO

2,5 g

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 12, 2023

Approval ID

0dfb3288796978f1

Type

Standard

Back to CIMA-AEMPS Approvals